Dentists in Hope Valley, RI Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Sihana Rugova, DDS, MSC Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 823 Main St, Hope Valley, RI 02832 Phone: 401-539-2461 |
Dr. Melanie Kay Dufour-pilny, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1035 Main St, Hope Valley, RI 02832 Phone: 401-539-1090 Fax: 401-539-7460 |
Dr. Roberta Nadeau Boatright, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 823 Main St, Hope Valley, RI 02832 Phone: 401-539-2461 Fax: 401-539-2663 |
Ms. Mary Frances Dzurinko, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 823 Main St, Hope Valley, RI 02832 Phone: 401-539-2461 Fax: 401-539-2663 |
Tiffanie Ann Marie Waldeck, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 823 Main St, Hope Valley, RI 02832 Phone: 401-539-2461 |
News Archive
A new treatment for Chlamydia via Canadian researchers
A new way to prevent and treat one of the commonest sexually transmitted infections (STIs) has been developed by the researchers at the University of Manitoba and the University of Waterloo. This new method is more of a gene therapy than antibiotic therapy against the infection.
Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
New technique for studying lifecycle of hepatitis B virus can help develop cure for disease
A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.
Oral bacteria in pancreas associated with tumor severity
The presence of oral bacteria in so-called cystic pancreatic tumours is associated with the severity of the tumour, a study by researchers at Karolinska Institutet in Sweden published in the journal Gut reports. It is hoped that the results can help to improve diagnosis and treatment of pancreatic cancer.
› Verified 1 days ago